11h
This Impinj Insider Sold 45,000 Shares Worth $7.7 Million. Did They Miss Out on Even Bigger Gains?
How does this transaction compare to Sylebra Capital's historical sale activity in Impinj? The 45,761 shares sold are below Sylebra's historical median for open-market sales, which stands at 51,307 ...
Tech Xplore on MSN
Detecting 'hidden defects' that degrade semiconductor performance with 1,000X higher sensitivity
Semiconductors are used in devices such as memory chips and solar cells, and within them may exist invisible defects that ...
The UK Information Commissioner’s Office is concerned about the data protection challenges presented by AI agents as they ...
Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix ...
Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix second phase 3 study initiated; two phase 3 studies in invasive fungal infecti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback